What is Jeuveau®
The goal of aging gracefully just keeps getting easier to obtain. The development of neurotoxins and other injectables are now routinely used to fight the effects of gravity and aging. Jeuveau™ is a recent advancement that is sitting alongside Botox® as an option for facial rejuvenation.
The Jeuveau™ injectable is made using the same 900 kDa protein that is found in Botox®, classifying it as a neuromodulator. As such, the FDA-approved cosmetic drug smoothes lines and wrinkles by relaxing muscle contractions. Jeuveau™ can also be used preventatively to prevent new lines from developing.
Benefits Of Jeuveau™
Aside from being a convenient anti-aging treatment, patients appreciate the fact that the active ingredient in Jeuveau™, 900 kDa purified botulinum toxin formula type A, has been proven safe and effective through its use in Botox® Cosmetic. This protein has been in use since the late 1980s and has very few risks associated with it. For Jeuveau™, no adverse reactions have been reported to date.
​
To gain FDA approval, the makers of Jeuveau™ put this drug through two clinical trials that involved double-blind placebo studies. In each trial, Jeuveau™ demonstrated high efficacy in meeting the primary goal of reducing glabellar lines in thirty days. In one study, 65.7% of patients achieved successful results. That statistic reached 70.4% in the second study.
​
Efficacy is one of the leading benefits of Jeuveau™ treatment, with safety also being high priority. Additionally, this treatment was developed solely for cosmetic use and is generally available at a lower cost than other neuromodulator treatments.